In conclusion, our prospective study showed that continuous IV administration of G-CSF with a high dose (16 micrograms/kg/day) could represent an effective alternative for neutropenic patients, especially for those without any response within 24 h to standard treatment or profound neutropenia. Here, CSF3 is linked to Decreased total neutrophil count.